Chicago, Illinois, March 28, 2008 – Vascular BioSciences announced today that Abraham Rothman, M.D., will present experimental data on the use of Vascular BioSciences’ endoarterial biopsy catheter in models of pulmonary hypertension, lung transplant rejection, and congenital heart disease at the Society for Cardiovascular Angiography and Interventions annual scientific sessions at this years American College of Cardiology Annual Innovation in Intervention Meeting. Dr. Rothmans presentation will be given from 3:00 to 4:00 pm at McCormick Place in Chicago, Illinois on March 30, 2008.
Dr. Rothman, a Professor of Pediatrics at the University of Nevada School of Medicine, and a Fellow of the American College of Cardiology, will present new techniques to assess pulmonary vascular gene expression, identify novel applications for existing drugs and describe new methods to deliver individualized pharmacogenomics for vascular diseases using endoarterial biopsy.
About Vascular BioSciences
Vascular BioSciences, a diversified biomedical company based in Research Triangle, North Carolina, provides solutions for vascular–based diseases in order to enhance and prolong human life.
Vascular BioSciences makes interventional catheters to obtain endoarterial biopsies, provides diagnostic services, and advances therapies in order to improve outcomes for vascular–based disease patients. More information is available at www.vascularbiosciences.com.